News und Analysen
DGAP-News: CEWE plant nach gutem Jahr auch 2022 mit starkem Ergebnis
DGAP-News: After a good year, CEWE also plans for strong results in 2022
DGAP-News: CEWE mit dreizehnter Dividendensteigerung in Folge
DGAP-News: CEWE increases dividend for thirteenth consecutive year
DGAP-News: Aufsichtsrat der CEWE Stiftung & Co. KGaA zur Nicht-Vertragsverlängerung des Vorstandsvorsitzenden Dr. Christian Friege
DGAP-News: Supervisory Board of CEWE Stiftung & Co. KGaA on the non-renewal of the CEO's contract of Dr. Christian Friege
DGAP-News: CEWE: Personal change
DGAP-News: CEWE: Personelle Veränderung
DGAP-Adhoc: CEWE Stiftung & Co. KGaA: Publication of inside information according to Article 17 of Regulation (EU) No. 596/2014
DGAP-Adhoc: CEWE Stiftung & Co. KGaA: Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014
IFF Announces Global Price Increases Across All Divisions
IFF (NYSE: IFF) today announced that it is implementing broad-based pricing actions across all four divisions – Nourish, Health & Biosciences, Scent, and Pharma Solutions. The immediate need for
IFF Announces Chief Human Resources Officer Transition
IFF (NYSE: IFF) today announced that Susana Suarez Gonzalez, PhD, Executive Vice President, Chief Human Resources and Diversity & Inclusion Officer, will be leaving the company, and Peter Sommers
IFF Declares Dividend for First Quarter 2022
IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.79 per share of its common stock, payable on April 6, 2022 to shareholders of record as of
DGAP-News: CEWE planning its thirteenth consecutive dividend increase
DGAP-Adhoc: CEWE planning its thirteenth consecutive dividend increase:
DGAP-Adhoc: CEWE plant dreizehnte Dividendensteigerung in Folge
IFF to Acquire Health Wright Products
IFF (NYSE: IFF) today announced that it has entered into an agreement to acquire Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement
IFF to Present at 2022 CAGNY Conference
IFF (NYSE: IFF) announced today that Executive Vice President and Chief Financial Officer Glenn Richter will be a featured speaker at the Consumer Analyst Group of New York's annual conference, to
IFF Reports Fourth Quarter and Full Year 2021 Results
International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2021.
Fourth Quarter 2021 Consolidated Summary:
Reporte
IFF Appoints Barry A. Bruno to Board of Directors
IFF (NYSE: IFF) today announced the appointment of Barry A. Bruno to the Company’s Board of Directors as an independent director, effective February 8, 2022.
“We are pleased to welcome Barry to
IFF to Release Fourth Quarter and Full Year 2021 Results February 9
IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2021 earnings results following the market close on Wednesday, February 9, 2022. The management team will host a
DGAP-News: CEWE also with strong results in 2021
DGAP-News: CEWE auch 2021 mit starkem Ergebnis
IFF Appoints Frank Clyburn as Chief Executive Officer and Board Director; Separates Chairman and Chief Executive Officer Roles
IFF (NYSE: IFF) today announced the appointment of Frank Clyburn, an accomplished leader and operational executive, to succeed Andreas Fibig as Chief Executive Officer and a member of the IFF Board
IFF and SleepScore Labs to Unveil Validated Scent Solutions to Support Improved Sleep at CES 2022
IFF (NYSE: IFF) and SleepScore Labs introduce a groundbreaking scent solution to improve sleep quality, building on the partnership initiated in 2020 and leveraging IFF’s internal Science of